FR2902329B1 - Utilisation de sulforaphane, de phenethyl isothiocyanate, de 6-methyl-sulphinyl)hexyl isothiocyanate et d'allyl isothiocyanate pour le traitement de la canitie. - Google Patents

Utilisation de sulforaphane, de phenethyl isothiocyanate, de 6-methyl-sulphinyl)hexyl isothiocyanate et d'allyl isothiocyanate pour le traitement de la canitie.

Info

Publication number
FR2902329B1
FR2902329B1 FR0611091A FR0611091A FR2902329B1 FR 2902329 B1 FR2902329 B1 FR 2902329B1 FR 0611091 A FR0611091 A FR 0611091A FR 0611091 A FR0611091 A FR 0611091A FR 2902329 B1 FR2902329 B1 FR 2902329B1
Authority
FR
France
Prior art keywords
isothiocyanate
canitia
sulforaphane
sulphinyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0611091A
Other languages
English (en)
Other versions
FR2902329A1 (fr
Inventor
Stephane Commo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0611091A priority Critical patent/FR2902329B1/fr
Publication of FR2902329A1 publication Critical patent/FR2902329A1/fr
Application granted granted Critical
Publication of FR2902329B1 publication Critical patent/FR2902329B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
FR0611091A 2006-12-19 2006-12-19 Utilisation de sulforaphane, de phenethyl isothiocyanate, de 6-methyl-sulphinyl)hexyl isothiocyanate et d'allyl isothiocyanate pour le traitement de la canitie. Active FR2902329B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0611091A FR2902329B1 (fr) 2006-12-19 2006-12-19 Utilisation de sulforaphane, de phenethyl isothiocyanate, de 6-methyl-sulphinyl)hexyl isothiocyanate et d'allyl isothiocyanate pour le traitement de la canitie.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0611091A FR2902329B1 (fr) 2006-12-19 2006-12-19 Utilisation de sulforaphane, de phenethyl isothiocyanate, de 6-methyl-sulphinyl)hexyl isothiocyanate et d'allyl isothiocyanate pour le traitement de la canitie.

Publications (2)

Publication Number Publication Date
FR2902329A1 FR2902329A1 (fr) 2007-12-21
FR2902329B1 true FR2902329B1 (fr) 2011-07-01

Family

ID=38001163

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0611091A Active FR2902329B1 (fr) 2006-12-19 2006-12-19 Utilisation de sulforaphane, de phenethyl isothiocyanate, de 6-methyl-sulphinyl)hexyl isothiocyanate et d'allyl isothiocyanate pour le traitement de la canitie.

Country Status (1)

Country Link
FR (1) FR2902329B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113694188A (zh) * 2021-10-15 2021-11-26 北京化工大学 用于改善和治疗白发和/或脱发的药物组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769837B1 (fr) * 1997-10-17 2000-02-25 Bio Sphere 99 Lab Composition pour dietetique ou cosmetique a base d'extraits vegetaux
JP3820800B2 (ja) * 1999-06-18 2006-09-13 王子製紙株式会社 育毛剤
FR2802417B1 (fr) * 1999-12-20 2003-10-31 Serobiologiques Lab Sa Preparations cosmetiques et/ou pharmaceutiques contenant au moins un extrait de brassicaceae
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
EP1262166A1 (fr) * 2001-06-01 2002-12-04 Cognis France S.A. Compositions cosmétiques et/ou pharmaceutiques contenant un extrait de Pterocarpus marsupium
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
FR2840530B1 (fr) * 2002-06-11 2004-12-24 Oreal Composition cosmetique comprenant un agent inducteur de l'expression de la dopachrome tautomerase (trp-2) pour lutter contre la canitie
FR2879444B1 (fr) * 2004-12-22 2007-05-18 Oreal Utilisation d'un compose capable d'augmenter le taux de glutathion dans les melanocytes pour le traitement de la canitie

Also Published As

Publication number Publication date
FR2902329A1 (fr) 2007-12-21

Similar Documents

Publication Publication Date Title
FR22C1033I1 (fr) Utilisation de dihydroimidazolones pour le traitement des chiens
FR2902325B1 (fr) Utilisation de 3h-1,2-dithiole-3-thione, d'anethole dithiomlethione, de sulforaphe, de phenethyl isothiocyanate, de 6-methyle-sulphinyl)hexyl isothiocyanate et d'allyl isothiocyanate pour le traitement de la canitie
FR2890306B1 (fr) Dispositif pour le traitement d'une poche vasculaire
FR2887450B1 (fr) Ingredient concentre pour le traitement et/ou la modification de surfaces, et son utilisation dans des compositions cosmetiques
FR2887139B1 (fr) Dispositif de traitement d'un vaisseau sanguin.
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
FR2898636B1 (fr) Structure de queue-d'aronde de soufflante.
FR2907677B1 (fr) Utilisation d'un copolymere bloc polysiloxane/polyuree pour le traitement des cheveux
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
FR2902010B1 (fr) Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatrique
FR2915102B1 (fr) Utilisation d'un anticorps anti-cxcr4 pour le traitement du cancer
FR2869217B1 (fr) Implant glenoidien pour prothese totale d'epaule inversee, et prothese totale d'epaule inversee le comprenant
FR2921795B1 (fr) Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
FR2896422B1 (fr) Systeme de drainage pour le traitement de l'hydrocephalie
FR2919187B1 (fr) Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2906468B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
FR2919305B1 (fr) Vecteurs viraux adeno-associes pour l'expression de la dysferline.
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
FR2902329B1 (fr) Utilisation de sulforaphane, de phenethyl isothiocyanate, de 6-methyl-sulphinyl)hexyl isothiocyanate et d'allyl isothiocyanate pour le traitement de la canitie.
FR2838052B1 (fr) Utilisation de particules metalliques organomodifiees pour le traitement de fibres keratiniques humaines
FR2912059B1 (fr) Utilisation d'argiles pour le traitement de la maladie coeliaque
FR2901703B1 (fr) Utilisation de zatosetron pour le traitement de la rosacee, et compositions pharmaceutiques
FR2868307B1 (fr) Utilisation de beta-endorphine pour le traitement des rides
DE502004007941D1 (de) Hydrodynamischer Retarder oder hydrodynamische Kupplung
FR2923064B1 (fr) Dispositif pour stimuler la memoire d'un patient.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12